169 related articles for article (PubMed ID: 35099639)
1. Comprehensive risk evaluation for metachronous carcinogenesis after endoscopic submucosal dissection of superficial pharyngeal squamous cell carcinoma.
Ogasawara N; Kikuchi D; Tanaka M; Ochiai Y; Okamura T; Hayasaka J; Suzuki Y; Mitsunaga Y; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S
Esophagus; 2022 Jul; 19(3):460-468. PubMed ID: 35099639
[TBL] [Abstract][Full Text] [Related]
2. Metachronous carcinogenesis of superficial esophagus squamous cell carcinoma after endoscopic submucosal dissection: incidence and risk stratification during long-term observation.
Ogasawara N; Kikuchi D; Inoshita N; Nakayama A; Kohno K; Ochiai Y; Hayasaka J; Suzuki Y; Dan N; Okamura T; Mitsunaga Y; Tanaka M; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S; Iizuka T
Esophagus; 2021 Oct; 18(4):806-816. PubMed ID: 33974189
[TBL] [Abstract][Full Text] [Related]
3. Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
Uno K; Koike T; Kusaka G; Takahashi Y; Ara N; Shimosegawa T
Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475742
[TBL] [Abstract][Full Text] [Related]
4. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Kim GH; Min YW; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
PLoS One; 2020; 15(9):e0238113. PubMed ID: 32886924
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of cervical lymph node metastasis in superficial pharyngeal squamous cell carcinoma after endoscopic submucosal dissection.
Ogasawara N; Kikuchi D; Tanaka M; Ochiai Y; Okamura T; Hayasaka J; Suzuki Y; Mitsunaga Y; Nomura K; Odagiri H; Yamashita S; Matsui A; Watanabe K; Takeda H; Hoteya S
Gastrointest Endosc; 2023 Oct; 98(4):524-533.e2. PubMed ID: 37150414
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in Taiwan.
Hsu MH; Wang WL; Chen TH; Tai CM; Wang HP; Lee CT
BMC Gastroenterol; 2021 Aug; 21(1):308. PubMed ID: 34344303
[TBL] [Abstract][Full Text] [Related]
8. Blue laser imaging identifies endoscopic findings corresponding to metachronous esophageal squamous cell carcinoma.
Azuma Y; Dohi O; Naito Y; Yasuda T; Yoshida T; Ishida T; Kitae H; Matsumura S; Doi T; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Takagi T; Ishikawa T; Konishi H; Nishimura A; Kishimoto M; Itoh Y
Esophagus; 2022 Apr; 19(2):278-286. PubMed ID: 34773554
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of endoscopic submucosal dissection in patients who develop metachronous superficial esophageal squamous cell carcinoma close to a post-endoscopic submucosal dissection scar.
Fukuhara M; Urabe Y; Oka S; Mizuno J; Tanaka H; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Arihiro K; Tanaka S
Esophagus; 2023 Jan; 20(1):124-133. PubMed ID: 35917040
[TBL] [Abstract][Full Text] [Related]
10. Association between the findings of metachronous secondary primary malignancies and the number of Lugol-voiding lesions.
Katada C; Yokoyama T; Yano T; Oda I; Shimizu Y; Takemura K; Koike T; Takizawa K; Hirao M; Okada H; Nakayama N; Kubota Y; Matsuo Y; Kawakubo H; Ishikawa H; Yokoyama A; Muto M
Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32052025
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of the aldehyde breath test for predicting metachronous recurrence in patients with esophageal squamous cell carcinoma and hypopharyngeal squamous cell carcinoma.
Sasaki F; Mawatari S; Oda K; Yano H; Maeda H; Tanaka A; Arima S; Kumagai K; Tanoue S; Hashimoto S; Kanmura S; Ido A
Esophagus; 2023 Oct; 20(4):749-756. PubMed ID: 37552454
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma.
Suzuki Y; Kikuchi D; Hoteya S; Okamura T; Ochiai Y; Hayasaka J; Dan N; Mitsunaga Y; Tanaka M; Odagiri H; Nomura K; Yamashita S; Matsui A; Iizuka T
Digestion; 2021; 102(4):622-629. PubMed ID: 32992320
[TBL] [Abstract][Full Text] [Related]
13. Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.
Katada C; Yokoyama T; Yano T; Kaneko K; Oda I; Shimizu Y; Doyama H; Koike T; Takizawa K; Hirao M; Okada H; Yoshii T; Konishi K; Yamanouchi T; Tsuda T; Omori T; Kobayashi N; Shimoda T; Ochiai A; Amanuma Y; Ohashi S; Matsuda T; Ishikawa H; Yokoyama A; Muto M
Gastroenterology; 2016 Nov; 151(5):860-869.e7. PubMed ID: 27492616
[TBL] [Abstract][Full Text] [Related]
14. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
[TBL] [Abstract][Full Text] [Related]
15. Similar survival after endoscopic submucosal dissection and esophagectomy in early esophageal cancer and synchronous or metachronous head and neck cancer.
Ke RT; Hsiao YH; Tai WC; Li SH; Yao CC; Chuang KH; Lai HH; Chen Y; Chen LC; Lu HI; Chen YH; Lo CM
J Cardiothorac Surg; 2024 Feb; 19(1):52. PubMed ID: 38311758
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for incomplete resection with pharyngeal endoscopic submucosal dissection and long-term prognosis after resection.
Sakaguchi Y; Saito Y; Ando M; Yoshida M; Fukuoka O; Kobayashi K; Kubota D; Ohki D; Mizutani H; Niimi K; Tsuji Y; Fujishiro M; Yamasoba T
Surg Endosc; 2023 May; 37(5):3593-3601. PubMed ID: 36624214
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
[TBL] [Abstract][Full Text] [Related]
19. Treatment strategy for superficial pharyngeal squamous cell carcinoma synchronously combined with esophageal cancer.
Kaneko K; Yano T; Minashi K; Kojima T; Ito M; Satake H; Yajima Y; Yoda Y; Ikematsu H; Oono Y; Hayashi R; Onozawa M; Ohtsu A
Oncology; 2013; 84(1):57-64. PubMed ID: 23128894
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors Linking Esophageal Squamous Cell Carcinoma With Head and Neck Cancer or Gastric Cancer.
Onochi K; Shiga H; Takahashi S; Watanabe N; Fukuda S; Ishioka M; Koizumi S; Matsuhasi T; Jin M; Iijima K
J Clin Gastroenterol; 2019 Apr; 53(4):e164-e170. PubMed ID: 29498952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
